-
EP3833681
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3833681
| EP3833681 - HA-1 SPECIFIC T CELL RECEPTORS AND THEIR USE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 24.03.2023 Database last updated on 26.04.2025 | |
| Former | Request for examination was made Status updated on 14.05.2021 | ||
| Former | The international publication has been made Status updated on 15.02.2020 | ||
| Former | unknown Status updated on 12.08.2019 | Most recent event Tooltip | 28.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Medigene Immunotherapies GmbH Lochhamer Straße 11 82152 Planegg-Martinsried / DE | [2021/24] | Inventor(s) | 01 /
ELLINGER, Christian Reisingerstr. 3 80337 München / DE | 02 /
SOMMERMEYER, Daniel Nördliche Auffahrtsallee 43 80638 München / DE | 03 /
BRACHER, Aline Albert-Roßhaupter-Str. 76b 81369 München / DE | [2021/24] | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
| Former [2021/24] | Wünsche, Annelie Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Elisenhof Elisenstraße 3 80335 München / DE | Application number, filing date | 19748549.3 | 06.08.2019 | [2021/24] | WO2019EP71099 | Priority number, date | EP20180187539 | 06.08.2018 Original published format: EP 18187539 | [2021/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020030631 | Date: | 13.02.2020 | Language: | EN | [2020/07] | Type: | A1 Application with search report | No.: | EP3833681 | Date: | 16.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.02.2020 takes the place of the publication of the European patent application. | [2021/24] | Search report(s) | International search report - published on: | EP | 13.02.2020 | (Supplementary) European search report - dispatched on: | EP | 22.03.2023 | Classification | IPC: | C07K14/725, C07K16/28 | [2021/24] | CPC: |
C07K14/7051 (EP,US);
C07K16/2833 (EP,US);
A61K38/00 (US);
C07K2317/565 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/24] | Title | German: | HA-1-SPEZIFISCHE T-ZELL-REZEPTOREN UND DEREN VERWENDUNG | [2021/24] | English: | HA-1 SPECIFIC T CELL RECEPTORS AND THEIR USE | [2021/24] | French: | RÉCEPTEURS DE LYMPHOCYTES T SPÉCIFIQUES DE HA-1 ET LEUR UTILISATION | [2021/24] | Entry into regional phase | 05.03.2021 | National basic fee paid | 05.03.2021 | Designation fee(s) paid | 05.03.2021 | Examination fee paid | Examination procedure | 05.03.2021 | Amendment by applicant (claims and/or description) | 05.03.2021 | Examination requested [2021/24] | 05.03.2021 | Date on which the examining division has become responsible | 22.03.2023 | Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M04) [2023/17] | 22.03.2023 | Despatch of a communication from the examining division (Time limit: M04) | 01.08.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 05.03.2021 | Renewal fee patent year 03 | 22.08.2022 | Renewal fee patent year 04 | 29.08.2023 | Renewal fee patent year 05 | 28.08.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IDA]WO2018058002 (HUTCHINSON FRED CANCER RES [US]); | by applicant | US4703004 | US4851341 | WO03020763 | EP2173869 | WO2018058002 |